MORE than 15,000 clinically vulnerable people have been urged to shield across Southampton.
More people have been advised to follow shielding guidance, after new technology has been introduced to help clinicians identify a new group of people who may be at high risk from Covid-19.
The technology is based upon risk factors or health issues which when combined, indicates a higher risk of becoming seriously unwell from coronavirus.
In Southampton, over 15,000 residents are now considered clinically extremely vulnerable and advised to shield. This means staying at home as much as possible until March 31, except to exercise or to attend health appointments, and to work from home if they can.
People identified through the risk assessment will be sent a letter from NHS England in the coming days explaining the details and will be invited to receive a Covid-19 vaccine as soon as possible if they haven’t had the jab already.
Leader of the council, Councillor Christopher Hammond said: “Supporting our most vulnerable residents continues to be a top priority, as it has been throughout the Covid-19 pandemic.
"While I know that this is understandably a worrying time for many, it’s good news that more residents, who are at higher risk of becoming seriously unwell will be offered the vaccine sooner.
"We stand ready to help anyone who needs support and encourage people to please contact the Covid-19 resident helpline if needed.”
Southampton City Council will also be contacting the additional residents who are now in the clinically extremely vulnerable group, signposting to the wide range of support available in the city.
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules hereComments are closed on this article